]>
IRCT20250207064676N1 IRCT 2025-04-02 Bagheiat-allah University of Medical Sciences Studying the effect of vitamin D on benign paroxysmal positional vertigo (BPPV) Evaluation of the effects of vitamin D in patients with benign paroxysmal positional vertigo (BPPV) 2025-04-21 anticipated 100 Complete https://irct.ir/trial/82442 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, simple random selection method using a random number table will be used to select individuals. In this way, the researcher first determines the direction of movement in the table and then randomly places her finger on one of the numbers in the table. Then it moves in the direction indicated in the table and records all the numbers. Even numbers will receive the intervention method and odd numbers the control method. 3 benign paroxysmal positional vertigo(bppv). Intervention 1: Intervention group : In the intervention group, in addition to standard BPPV treatment (Epley maneuver It is a treatment method performed by a physician and involves a series of four head and body movements from sitting to lying down, rolling to the side, and returning to a sitting position.), one 1000-unit vitamin D supplement tablet (Dana Pharma) is prescribed once daily with food until the end of the study (6 months). The dose of vitamin D used in this study is within the daily requirement and completely safe. Intervention 2: Control group: In this group, only the Epley maneuver is performed, which is the standard treatment, and vitamin D supplementation is not prescribed, and the patient is advised not to take vitamin D until the end of the study. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is Information may be published after collection and verification.
public Abas Rezaeezade
Block332, Daneshjoo street ,Velayat city ,Babaei Highway
Tehran Iran (Islamic Republic of) 1698749511 +98 83 4814 2376 arezaeezade72a91@gmail.com Bagheiat-allah University of Medical Sciences scientific Abas Rezaeezade
Block332, Daneshjoo street, Velayat city, Babaei Highway
Tehran Iran (Islamic Republic of) 1698741195 +98 83 4814 2376 arezaeezade72a91@gmail.com Bagheiat-allah University of Medical Sciences Iran (Islamic Republic of) Patients with confirmed benign paroxysmal positional vertigo (BPPV) Over 18 years old Serum vitamin D levels should be between 30 and 50 18 years no limit Both Failure to complete the informed consent form Taking drugs that affect vitamin D metabolism History of ear surgery History of Meniere's disease History of labyrinthitis or vestibular neuritis Pregnancy or breastfeeding H81.1 Benign paroxysmal vertigo Treatment - Drugs Treatment - Drugs Intervention group : In the intervention group, in addition to standard BPPV treatment (Epley maneuver It is a treatment method performed by a physician and involves a series of four head and body movements from sitting to lying down, rolling to the side, and returning to a sitting position.), one 1000-unit vitamin D supplement tablet (Dana Pharma) is prescribed once daily with food until the end of the study (6 months). The dose of vitamin D used in this study is within the daily requirement and completely safe. Control group: In this group, only the Epley maneuver is performed, which is the standard treatment, and vitamin D supplementation is not prescribed, and the patient is advised not to take vitamin D until the end of the study. Number of attacks of benign paroxysmal positional vertigo. Timepoint: Evaluation of benign paroxysmal positional vertigo before intervention and one month, three months, and six months after intervention. Method of measurement: Patient history in the form of a checklist and Hall-Pike maneuver (which is a diagnostic maneuver). Time interval between attacks of benign paroxysmal positional vertigo. Timepoint: Evaluation of benign paroxysmal positional vertigo before intervention and one month, three months, and six months after intervention. Method of measurement: Patient history in the form of a checklist and Hall-Pike maneuver (which is a diagnostic maneuver). Duration of benign paroxysmal positional vertigo attack. Timepoint: Evaluation of benign paroxysmal positional vertigo before intervention and one month, three months, and six months after intervention. Method of measurement: Patient history in the form of a checklist and Hall-Pike maneuver (which is a diagnostic maneuver). Severity of benign paroxysmal positional vertigo attacks. Timepoint: Evaluation of benign paroxysmal positional vertigo before intervention and one month, three months, and six months after intervention. Method of measurement: Patient history in the form of a checklist and Hall-Pike maneuver (which is a diagnostic maneuver). Symptoms associated with benign paroxysmal positional vertigo. Timepoint: Evaluation of benign paroxysmal positional vertigo before intervention and one month, three months, and six months after intervention. Method of measurement: Patient history in the form of a checklist and Hall-Pike maneuver (which is a diagnostic maneuver). Bagheiat-allah University of Medical Sciences Approved 2025-01-20 Ethics Committee of Baqiyatallah University of Medical Sciences Baqiyatollah University , Molla Sadra Street, Tehran Tehran Tehran Iran (Islamic Republic of)